Haematopoietic stem cell transplantation for patients with ... - PubMed
pubmed.ncbi.nlm.nih.gov › ...
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic ...
Hematopoietic cell transplantation (HCT) is an effective treatment for myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML). In this study, outcome ...
Missing: Haematopoietic Leukaemia
This report describes an analysis of the data from 1378 patients transplanted for MDS or secondary acute myeloid leukaemia (MDS-AML). We focused on prognostic ...
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the chronic ...
Jan 1, 2000 · leukaemias: a report on behalf of the chronic leukaemia working party of the European group for blood and marrow transplantation (EBMT).
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic ...
People also ask
What is the life expectancy of a stem cell transplant for MDS?
What is a hematopoietic stem cell transplant in cancer treatment?
Can stem cell transplant cure acute myeloid leukemia?
What is the most serious complication of hematopoietic stem cell transplant?
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: a report on behalf of the Chronic ...
Missing: Leukaemia | Show results with:Leukaemia
Three studies by the European Bone Marrow Transplant (EBMT) group have investigated the use of autologous HSCT for MDS and treatment-related AML. In a large ...
Mar 30, 2017 · A recent study in 401 patients who received HSCT for MDS or MDS/acute myeloid leukemia (AML) showed that somatic mutations in ASXL1, RUNX1, or ...
Abstract. Allogeneic stem cell transplantation is a potentially curative treatment for myelodysplastic syndromes. Transplants are clearly indicated in patients ...